-
1
-
-
74049160009
-
Mechanisms maintaining peripheral tolerance
-
Mueller DL. Mechanisms maintaining peripheral tolerance. Nat Immunol. 2010;11(1):21-27.
-
(2010)
Nat Immunol
, vol.11
, Issue.1
, pp. 21-27
-
-
Mueller, D.L.1
-
2
-
-
77954141914
-
FOXP3+ regulatory T cells in the human immune system
-
Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol. 2010; 10(7):490-500.
-
(2010)
Nat Rev Immunol
, vol.10
, Issue.7
, pp. 490-500
-
-
Sakaguchi, S.1
Miyara, M.2
Costantino, C.M.3
Hafler, D.A.4
-
3
-
-
1242295282
-
+ immunoregulatory T cells: Central players in the arena of peripheral tolerance
-
DOI 10.1016/j.smim.2003.12.003
-
Piccirillo CA, Shevach EM. Naturally-occurring CD4+ CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin Immunol. 2004;16(2):81-88. (Pubitemid 38234759)
-
(2004)
Seminars in Immunology
, vol.16
, Issue.2
, pp. 81-88
-
-
Piccirillo, C.A.1
Shevach, E.M.2
-
4
-
-
51049083609
-
The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: Implications for immunotherapy
-
Lehe C, Ghebeh H, Al-Sulaiman A, et al. The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy. Cancer Res. 2008;68(15):6350-6359.
-
(2008)
Cancer Res
, vol.68
, Issue.15
, pp. 6350-6359
-
-
Lehe, C.1
Ghebeh, H.2
Al-Sulaiman, A.3
-
5
-
-
23044463715
-
+ helper T cell responses in cancer patients
-
DOI 10.1182/blood-2005-02-0607
-
Nishikawa H, Jager E, Ritter G, Old LJ, Gnjatic S. CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients. Blood. 2005; 106(3):1008-1011. (Pubitemid 41076447)
-
(2005)
Blood
, vol.106
, Issue.3
, pp. 1008-1011
-
-
Nishikawa, H.1
Jager, E.2
Ritter, G.3
Old, L.J.4
Gnjatic, S.5
-
6
-
-
30444443314
-
Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines
-
DOI 10.1182/blood-2005-07-2737
-
Zhou G, Drake CG, Levitsky HI. Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines. Blood. 2006;107(2):628-636. (Pubitemid 43076387)
-
(2006)
Blood
, vol.107
, Issue.2
, pp. 628-636
-
-
Zhou, G.1
Drake, C.G.2
Levitsky, H.I.3
-
7
-
-
68149155982
-
Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies
-
Peggs KS, Quezada SA, Chambers CA, Korman AJ, Allison JP. Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies. J Exp Med. 2009;206(8): 1717-1725.
-
(2009)
J Exp Med
, vol.206
, Issue.8
, pp. 1717-1725
-
-
Peggs, K.S.1
Quezada, S.A.2
Chambers, C.A.3
Korman, A.J.4
Allison, J.P.5
-
9
-
-
4644237613
-
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
-
DOI 10.1038/nm1093
-
Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004;10(9):942-949. (Pubitemid 39273735)
-
(2004)
Nature Medicine
, vol.10
, Issue.9
, pp. 942-949
-
-
Curiel, T.J.1
Coukos, G.2
Zou, L.3
Alvarez, X.4
Cheng, P.5
Mottram, P.6
Evdemon-Hogan, M.7
Conejo-Garcia, J.R.8
Zhang, L.9
Burow, M.10
Zhu, Y.11
Wei, S.12
Kryczek, I.13
Daniel, B.14
Gordon, A.15
Myers, L.16
Lackner, A.17
Disis, M.L.18
Knutson, K.L.19
Chen, L.20
Zou, W.21
more..
-
10
-
-
0035903307
-
+ regulatory T cells
-
DOI 10.1084/jem.194.6.847
-
Iellem A, Mariani M, Lang R, et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med. 2001;194(6):847-853. (Pubitemid 32983019)
-
(2001)
Journal of Experimental Medicine
, vol.194
, Issue.6
, pp. 847-853
-
-
Iellem, A.1
Mariani, M.2
Lang, R.3
Recalde, H.4
Panina-Bordignon, P.5
Sinigaglia, F.6
D'Ambrosio, D.7
-
11
-
-
33749144742
-
+ regulatory T cells bear functional skin-homing receptors
-
Hirahara K, Liu L, Clark RA, Yamanaka K, Fuhlbrigge RC, Kupper TS. The majority of human peripheral blood CD4+CD25highFoxp3+regulatory T cells bear functional skin-homing receptors. J Immunol. 2006;177(7):4488-4494. (Pubitemid 44469779)
-
(2006)
Journal of Immunology
, vol.177
, Issue.7
, pp. 4488-4494
-
-
Hirahara, K.1
Liu, L.2
Clark, R.A.3
Yamanaka, K.-I.4
Fuhlbrigge, R.C.5
Kupper, T.S.6
-
12
-
-
33947655511
-
+ regulatory T cells
-
Bayry J, Triebel F, Kaveri SV, Tough DF. Human dendritic cells acquire a semimature phenotype and lymph node homing potential through interaction with CD4+CD25+ regulatory T cells. J Immunol. 2007;178(7):4184-4193. (Pubitemid 46492369)
-
(2007)
Journal of Immunology
, vol.178
, Issue.7
, pp. 4184-4193
-
-
Bayry, J.1
Triebel, F.2
Kaveri, S.V.3
Tough, D.F.4
-
13
-
-
33645067654
-
Regulatory T cells inhibit stable contacts between CD4+T cells and dendritic cells in vivo
-
Tadokoro CE, Shakhar G, Shen S, et al. Regulatory T cells inhibit stable contacts between CD4+T cells and dendritic cells in vivo. J Exp Med. 2006;203(3):505-511.
-
(2006)
J Exp Med
, vol.203
, Issue.3
, pp. 505-511
-
-
Tadokoro, C.E.1
Shakhar, G.2
Shen, S.3
-
14
-
-
48249150707
-
In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination
-
Bayry J, Tchilian EZ, Davies MN, et al. In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination. Proc Natl Acad Sci U S A. 2008;105(29):10221-10226.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, Issue.29
, pp. 10221-10226
-
-
Bayry, J.1
Tchilian, E.Z.2
Davies, M.N.3
-
15
-
-
77951239027
-
Toward the discovery of vaccine adjuvants: Coupling in silico screening and in vitro analysis of antagonist binding to human and mouse CCR4 receptors
-
Davies MN, Bayry J, Tchilian EZ, et al. Toward the discovery of vaccine adjuvants: coupling in silico screening and in vitro analysis of antagonist binding to human and mouse CCR4 receptors. PLoS One. 2009;4(11):e8084.
-
(2009)
PLoS One
, vol.4
, Issue.11
-
-
Davies, M.N.1
Bayry, J.2
Tchilian, E.Z.3
-
16
-
-
5144235393
-
Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen
-
DOI 10.1073/pnas.0405743101
-
Lonchay C, van der Bruggen P, Connerotte T, et al. Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen. Proc Natl Acad Sci U S A. 2004;101(Suppl 2):14631-14638. (Pubitemid 39346735)
-
(2004)
Proceedings of the National Academy of Sciences of the United States of America
, vol.101
, Issue.SUPPL. 2
, pp. 14631-14638
-
-
Lonchay, C.1
Van Der, B.P.D.2
Connerotte, T.3
Hanagiri, T.4
Coulie, P.5
Colau, D.6
Lucas, S.7
Van Pel, A.8
Thielemans, K.9
Van Baren, N.10
Boon, T.11
-
17
-
-
16444377935
-
+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer
-
DOI 10.1158/0008-5472.CAN-04-3444
-
Daniel D, Chiu C, Giraudo E, et al. CD4+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer. Cancer Res. 2005;65(5):2018-2025. (Pubitemid 40478632)
-
(2005)
Cancer Research
, vol.65
, Issue.5
, pp. 2018-2025
-
-
Daniel, D.1
Chiu, C.2
Giraudo, E.3
Inoue, M.4
Mizzen, L.A.5
Chu, N.R.6
Hanahan, D.7
-
18
-
-
34447119507
-
Spontaneous mammary tumors differ widely in their inherent sensitivity to adoptively transferred T cells
-
DOI 10.1158/0008-5472.CAN-07-0622
-
Wall EM, Milne K, Martin ML, Watson PH, Theiss P, Nelson BH. Spontaneous mammary tumors differ widely in their inherent sensitivity to adoptively transferred T cells. Cancer Res. 2007; 67(13):6442-6450. (Pubitemid 47037529)
-
(2007)
Cancer Research
, vol.67
, Issue.13
, pp. 6442-6450
-
-
Wall, E.M.1
Milne, K.2
Martin, M.L.3
Watson, P.H.4
Theiss, P.5
Nelson, B.H.6
-
19
-
-
15244354286
-
Regulatory T cell lineage specification by the forkhead transcription factor Foxp3
-
DOI 10.1016/j.immuni.2005.01.016
-
Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 2005;22(3):329-341. (Pubitemid 40387475)
-
(2005)
Immunity
, vol.22
, Issue.3
, pp. 329-341
-
-
Fontenot, J.D.1
Rasmussen, J.P.2
Williams, L.M.3
Dooley, J.L.4
Farr, A.G.5
Rudensky, A.Y.6
-
20
-
-
33646569995
-
The Shiga toxin B-subunit targets antigen in vivo to dendritic cells and elicits anti-tumor immunity
-
Vingert B, Adotevi O, Patin D, et al. The Shiga toxin B-subunit targets antigen in vivo to dendritic cells and elicits anti-tumor immunity. Eur J Immunol. 2006;36(5):1124-1135.
-
(2006)
Eur J Immunol
, vol.36
, Issue.5
, pp. 1124-1135
-
-
Vingert, B.1
Adotevi, O.2
Patin, D.3
-
21
-
-
38049021296
-
B sub-unit of Shiga toxin-based vaccines synergize with {alpha}-galactosylceramide to break tolerance against self antigen and elicit antiviral immunity
-
Adotevi O, Vingert B, Freyburger L, et al. B sub-unit of Shiga toxin-based vaccines synergize with {alpha}-galactosylceramide to break tolerance against self antigen and elicit antiviral immunity. J Immunol. 2007;179(5):3371-3379.
-
(2007)
J Immunol
, vol.179
, Issue.5
, pp. 3371-3379
-
-
Adotevi, O.1
Vingert, B.2
Freyburger, L.3
-
22
-
-
28944442195
-
Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1
-
DOI 10.1016/j.micinf.2005.05.024, PII S1286457905002443
-
Lasaro MO, Diniz MO, Reyes-Sandoval A, Ertl HC, Ferreira LC. Anti-tumor DNA vaccines based on the expression of human papillomavirus- 16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1. Microbes Infect. 2005;7(15):1541-1550. (Pubitemid 41785728)
-
(2005)
Microbes and Infection
, vol.7
, Issue.15
, pp. 1541-1550
-
-
Lasaro, M.O.1
Diniz, M.O.2
Reyes-Sandoval, A.3
Ertl, H.C.4
Ferreira, L.C.S.5
-
23
-
-
41149178490
-
Comparative methodologies of regulatory T cell depletion in a murine melanoma model
-
Matsushita N, Pilon-Thomas SA, Martin LM, Riker AI. Comparative methodologies of regulatory T cell depletion in a murine melanoma model. J Immunol Methods. 2008;333(1-2):167-179.
-
(2008)
J Immunol Methods
, vol.333
, Issue.1-2
, pp. 167-179
-
-
Matsushita, N.1
Pilon-Thomas, S.A.2
Martin, L.M.3
Riker, A.I.4
-
24
-
-
0043244853
-
+ regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo
-
DOI 10.1084/jem.20030654
-
Oldenhove G, de Heusch M, Urbain-Vansanten G, et al. CD4+CD25+ regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo. J Exp Med. 2003;198(2):259-266. (Pubitemid 36987851)
-
(2003)
Journal of Experimental Medicine
, vol.198
, Issue.2
, pp. 259-266
-
-
Oldenhove, G.1
De Heusch, M.2
Urbain-Vansanten, G.3
Urbain, J.4
Maliszewski, C.5
Leo, O.6
Moser, M.7
-
25
-
-
40749107481
-
Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients
-
DOI 10.1097/CJI.0b013e318159f5ba, PII 0000237120080100000012
-
Bercovici N, Haicheur N, Massicard S, et al. Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients. J Immunother. 2008;31(1): 101-112. (Pubitemid 351619409)
-
(2008)
Journal of Immunotherapy
, vol.31
, Issue.1
, pp. 101-112
-
-
Bercovici, N.1
Haicheur, N.2
Massicard, S.3
Vernel-Pauillac, F.4
Adotevi, O.5
Landais, D.6
Gorin, I.7
Robert, C.8
Miles, P.H.9
Grob, J.-J.10
Leccia, M.T.11
Lesimple, T.12
Wijdenes, J.13
Bartholeyns, J.14
Fridman, W.H.15
Salcedo, M.16
Ferries, E.17
Tartour, E.18
-
26
-
-
33947644716
-
+ T regulatory cells
-
Davidson TS, DiPaolo RJ, Andersson J, Shevach EM. Cutting Edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells. J Immunol. 2007;178(7):4022-4026. (Pubitemid 46492349)
-
(2007)
Journal of Immunology
, vol.178
, Issue.7
, pp. 4022-4026
-
-
Davidson, T.S.1
DiPaolo, R.J.2
Andersson, J.3
Shevach, E.M.4
-
27
-
-
78649890647
-
Prolonged antigen storage endows merocytic dendritic cells with enhanced capacity to prime anti-tumor responses in tumor-bearing mice
-
Reboulet RA, Hennies CM, Garcia Z, Nierkens S, Janssen EM. Prolonged antigen storage endows merocytic dendritic cells with enhanced capacity to prime anti-tumor responses in tumor-bearing mice. J Immunol. 2010;185(6):3337-3347.
-
(2010)
J Immunol
, vol.185
, Issue.6
, pp. 3337-3347
-
-
Reboulet, R.A.1
Hennies, C.M.2
Garcia, Z.3
Nierkens, S.4
Janssen, E.M.5
-
28
-
-
0034665096
-
The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens
-
Haicheur N, Bismuth E, Bosset S, et al. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens. J Immunol. 2000;165(6):3301-3308.
-
(2000)
J Immunol
, vol.165
, Issue.6
, pp. 3301-3308
-
-
Haicheur, N.1
Bismuth, E.2
Bosset, S.3
-
29
-
-
33747891558
-
Immunosurveillance of Erbb2 carcinogenesis in transgenic mice is concealed by a dominant regulatory T-cell self-tolerance
-
DOI 10.1158/0008-5472.CAN-06-1432
-
Ambrosino E, Spadaro M, Iezzi M, et al. Immuno-surveillance of Erbb2 carcinogenesis in transgenic mice is concealed by a dominant regulatory T-cell self-tolerance. Cancer Res. 2006;66(15): 7734-7740. (Pubitemid 44289233)
-
(2006)
Cancer Research
, vol.66
, Issue.15
, pp. 7734-7740
-
-
Ambrosino, E.1
Spadaro, M.2
Iezzi, M.3
Curcio, C.4
Forni, G.5
Musiani, P.6
Wei, W.-Z.7
Cavallo, F.8
-
30
-
-
58249111461
-
Genetic regulation of the response to Her-2 DNA vaccination in human Her-2 transgenic mice
-
Radkevich-Brown O, Jacob J, Kershaw M, Wei WZ. Genetic regulation of the response to Her-2 DNA vaccination in human Her-2 transgenic mice. Cancer Res. 2009;69(1):212-218.
-
(2009)
Cancer Res
, vol.69
, Issue.1
, pp. 212-218
-
-
Radkevich-Brown, O.1
Jacob, J.2
Kershaw, M.3
Wei, W.Z.4
-
31
-
-
33744925146
-
Vaccination with human HER-2/neu (435-443) CTL peptide induces effective antitumor immunity against HER-2/neu/-expressing tumor cells in vivo
-
DOI 10.1158/0008-5472.CAN-05-4018
-
Gritzapis AD, Mahaira LG, Perez SA, Cacoullos NT, Papamichail M, Baxevanis CN. Vaccination with human HER-2/neu (435-443) CTL peptide induces effective antitumor immunity against HER-2/neu-expressing tumor cells in vivo. Cancer Res. 2006;66(10):5452-5460. (Pubitemid 43844973)
-
(2006)
Cancer Research
, vol.66
, Issue.10
, pp. 5452-5460
-
-
Gritzapis, A.D.1
Mahaira, L.G.2
Perez, S.A.3
Cacoullos, N.T.4
Papamichail, M.5
Baxevanis, C.N.6
-
32
-
-
62449250053
-
Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome
-
Gobert M, Treilleux I, Bendriss-Vermare N, et al. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res. 2009;69(5):2000-2009.
-
(2009)
Cancer Res
, vol.69
, Issue.5
, pp. 2000-2009
-
-
Gobert, M.1
Treilleux, I.2
Bendriss-Vermare, N.3
-
33
-
-
34247120690
-
- Tregs, regulate effector T cells using FasL
-
Baatar D, Olkhanud P, Sumitomo K, Taub D, Gress R, Biragyn A. Human peripheral blood T regulatory cells (Tregs), functionally primed CCR4+ Tregs and unprimed CCR4- Tregs, regulate effector T cells using FasL. J Immunol. 2007; 178(8):4891-4900. (Pubitemid 46595271)
-
(2007)
Journal of Immunology
, vol.178
, Issue.8
, pp. 4891-4900
-
-
Baatar, D.1
Olkhanud, P.2
Sumitomo, K.3
Taub, D.4
Gress, R.5
Biragyn, A.6
-
35
-
-
35548950221
-
Regulatory T-cell inhibition versus depletion: The right choice in cancer immunotherapy
-
DOI 10.1038/nrc2250, PII NRC2250
-
Colombo MP, Piconese S. Regulatory-T-cell inhibition versus depletion: the right choice in cancer immunotherapy. Nat Rev Cancer. 2007;7(11): 880-887. (Pubitemid 350006256)
-
(2007)
Nature Reviews Cancer
, vol.7
, Issue.11
, pp. 880-887
-
-
Colombo, M.P.1
Piconese, S.2
-
36
-
-
66249095192
-
Cyclophosphamide augments antitumor immunity: Studies in an autochthonous prostate cancer model
-
Wada S, Yoshimura K, Hipkiss EL, et al. Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model. Cancer Res. 2009;69(10):4309-4318.
-
(2009)
Cancer Res
, vol.69
, Issue.10
, pp. 4309-4318
-
-
Wada, S.1
Yoshimura, K.2
Hipkiss, E.L.3
-
37
-
-
50949115267
-
Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines
-
Morse MA, Hobeika AC, Osada T, et al. Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines. Blood. 2008;112(3):610-618.
-
(2008)
Blood
, vol.112
, Issue.3
, pp. 610-618
-
-
Morse, M.A.1
Hobeika, A.C.2
Osada, T.3
-
38
-
-
30144444279
-
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells
-
DOI 10.1172/JCI25947
-
Dannull J, Su Z, Rizzieri D, et al. Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J Clin Invest. 2005;115(12):3623-3633. (Pubitemid 43121851)
-
(2005)
Journal of Clinical Investigation
, vol.115
, Issue.12
, pp. 3623-3633
-
-
Dannull, J.1
Su, Z.2
Rizzieri, D.3
Yang, B.K.4
Coleman, D.5
Yancey, D.6
Zhang, A.7
Dahm, P.8
Chao, N.9
Gilboa, E.10
Vieweg, J.11
-
39
-
-
27444435581
-
389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma
-
Attia P, Maker AV, Haworth LR, Rogers-Freezer L, Rosenberg SA. Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma. J Immunother. 2005;28(6):582-592. (Pubitemid 41533092)
-
(2005)
Journal of Immunotherapy
, vol.28
, Issue.6
, pp. 582-592
-
-
Attia, P.1
Maker, A.V.2
Haworth, L.R.3
Rogers-Freezer, L.4
Rosenberg, S.A.5
-
40
-
-
36148939150
-
IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity
-
DOI 10.1182/blood-2007-06-094615
-
Litzinger MT, Fernando R, Curiel TJ, Grosenbach DW, Schlom J, Palena C. IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity. Blood. 2007;110(9):3192-3201. (Pubitemid 350106311)
-
(2007)
Blood
, vol.110
, Issue.9
, pp. 3192-3201
-
-
Litzinger, M.T.1
Fernando, R.2
Curiel, T.J.3
Grosenbach, D.W.4
Schlom, J.5
Palena, C.6
-
41
-
-
34247380237
-
+ regulatory T cells
-
DOI 10.1084/jem.20061405
-
Schneider MA, Meingassner JG, Lipp M, Moore HD, Rot A. CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells. J Exp Med. 2007;204(4):735-745. (Pubitemid 46631604)
-
(2007)
Journal of Experimental Medicine
, vol.204
, Issue.4
, pp. 735-745
-
-
Schneider, M.A.1
Meingassner, J.G.2
Lipp, M.3
Moore, H.D.4
Rot, A.5
-
42
-
-
29244482759
-
Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice
-
DOI 10.1038/ni1289, PII N1289
-
Tang Q, Adams JY, Tooley AJ, et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol. 2006;7(1):83-92. (Pubitemid 41823872)
-
(2006)
Nature Immunology
, vol.7
, Issue.1
, pp. 83-92
-
-
Tang, Q.1
Adams, J.Y.2
Tooley, A.J.3
Bi, M.4
Fife, B.T.5
Serra, P.6
Santamaria, P.7
Locksley, R.M.8
Krummel, M.F.9
Bluestone, J.A.10
-
43
-
-
34250321683
-
CCR4-dependent regulatory T cell function in inflammatory bowel disease
-
DOI 10.1084/jem.20062076
-
Yuan Q, Bromley SK, Means TK, et al. CCR4-dependent regulatory T cell function in inflammatory bowel disease. J Exp Med. 2007;204(6): 1327-1334. (Pubitemid 46919871)
-
(2007)
Journal of Experimental Medicine
, vol.204
, Issue.6
, pp. 1327-1334
-
-
Yuan, Q.1
Bromley, S.K.2
Means, T.K.3
Jones, K.J.4
Hayashi, F.5
Bhan, A.K.6
Luster, A.D.7
-
44
-
-
17144393320
-
+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor
-
DOI 10.1084/jem.20041709
-
Lee I, Wang L, Wells AD, Dorf ME, Ozkaynak E, Hancock WW. Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med. 2005;201(7):1037-1044. (Pubitemid 40524671)
-
(2005)
Journal of Experimental Medicine
, vol.201
, Issue.7
, pp. 1037-1044
-
-
Lee, I.1
Wang, L.2
Wells, A.D.3
Dorf, M.E.4
Ozkaynak, E.5
Hancock, W.W.6
-
45
-
-
77949830320
-
Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs
-
Semmling V, Lukacs-Kornek V, Thaiss CA, et al. Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs. Nat Immunol. 2010;11(4):313-320.
-
(2010)
Nat Immunol
, vol.11
, Issue.4
, pp. 313-320
-
-
Semmling, V.1
Lukacs-Kornek, V.2
Thaiss, C.A.3
-
46
-
-
67650638846
-
T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model
-
Di Stasi A, De Angelis B, Rooney CM, et al. T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model. Blood. 2009;113(25):6392-6402.
-
(2009)
Blood
, vol.113
, Issue.25
, pp. 6392-6402
-
-
Di Stasi, A.1
De Angelis, B.2
Rooney, C.M.3
-
47
-
-
34250336452
-
+ regulatory T cells results in tissue-specific inflammatory disease
-
DOI 10.1084/jem.20070081
-
Sather BD, Treuting P, Perdue N, et al. Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease. J Exp Med. 2007;204(6):1335-1347. (Pubitemid 46919872)
-
(2007)
Journal of Experimental Medicine
, vol.204
, Issue.6
, pp. 1335-1347
-
-
Sather, B.D.1
Treuting, P.2
Perdue, N.3
Miazgowicz, M.4
Fontenot, J.D.5
Rudensky, A.Y.6
Campbell, D.J.7
-
48
-
-
22144466887
-
+ Tregs
-
DOI 10.1172/JCI23963
-
Valmori D, Merlo A, Souleimanian NE, Hesdorffer CS, Ayyoub M. A peripheral circulating compartment of natural naive CD4 Tregs. J Clin Invest. 2005;115(7):1953-1962. (Pubitemid 40979735)
-
(2005)
Journal of Clinical Investigation
, vol.115
, Issue.7
, pp. 1953-1962
-
-
Valmori, D.1
Merlo, A.2
Souleimanian, N.E.3
Hesdorffer, C.S.4
Ayyoub, M.5
|